Company AXIM Biotechnologies, Inc. Other OTC
Equities
AXIM
US05463V1008
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +345.27% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +345.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Huemoeller
CEO | Chief Executive Officer | 68 | - |
Robert Malasek
DFI | Director of Finance/CFO | 55 | 28/06/16 |
Kurt Phinney
COO | Chief Operating Officer | - | 22/05/23 |
Joseph Tauber
CTO | Chief Tech/Sci/R&D Officer | 67 | 20/09/21 |
Jeffrey A. Busby
PRN | Corporate Officer/Principal | - | 14/09/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Huemoeller
CEO | Chief Executive Officer | 68 | - |
Timothy Scott
BRD | Director/Board Member | 71 | 17/05/17 |
Director/Board Member | 76 | 17/05/17 | |
Blake Schroeder
BRD | Director/Board Member | 48 | - |
Peter O'Rourke
BRD | Director/Board Member | 76 | 20/07/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 500,000 | 0 | 0 | 71.61 % |
Stock B | 1 | 278,429,403 | 199,384,612 ( 71.61 %) | 0 |
Company contact information
AXIM Biotechnologies, Inc.
6191 Cornerstone Court East Suite 114
92121, San Diego
+
http://www.aximbiotech.comSector
1st Jan change | Capi. | |
---|---|---|
+22.18% | 47.9B | |
+46.56% | 41.42B | |
-2.34% | 40.7B | |
-6.20% | 28.92B | |
+10.68% | 25.55B | |
-21.33% | 19.27B | |
-1.48% | 12.15B | |
+31.19% | 12.14B | |
-0.41% | 11.99B |